文献速递神经头颈MR

眶内动眼神经STIR高信号对动眼神经麻痹的诊断价值

Diagnostic Value of Intra-orbital Oculomotor Nerve Short Tau Inversion Recovery Hyperintensity in Oculomotor Nerve Palsy.
PubMed 文献 · AJNR Am J Neuroradiol · 2026-08-13

本研究回顾性纳入31例动眼神经麻痹患者与43例正常对照,评价眶内段动眼神经STIR高信号这一征象,并与GRE增强T1WI比较。结果显示眶内段STIR高信号敏感度90.3%、特异度100%、准确度95.9%,且可在部分增强T1WI阴性患者中显示相应异常。

要点

  • 眶内段动眼神经STIR高信号是动眼神经麻痹较敏感且特异的影像征象
  • STIR可在部分增强T1WI未见异常的患者中显示动眼神经异常
  • 眼眶STIR可作为常规MRI方案的无对比剂补充序列

核心结论

  • 眶内动眼神经STIR高信号在不同病因动眼神经麻痹中常见,可作为临床诊断动眼神经麻痹的影像相关表现
  • 眼眶STIR成像可作为常规MRI方案中有用的无对比剂补充检查

研究设计与样本

  • 回顾性、单中心研究
  • 共74例受试者,包括31例动眼神经麻痹患者和43例正常对照,其中25例患者和30例对照有增强T1WI
  • 男性40例,女性34例,中位年龄68岁
  • 检查序列为眼眶2D STIR,参考标准为临床诊断

关键影像表现/征象

  • 病变水平分析中,眶内段STIR高信号在三个STIR评价节段中敏感度和准确度最高
  • 25例同时行两种序列的动眼神经麻痹患者中,7例在增强T1WI上未显示相应异常而STIR显示异常

诊断标准与关键数值

  • 眶内段STIR高信号:敏感度90.3%,特异度100%,准确度95.9%
  • 同节段GRE增强T1WI:敏感度12.0%,特异度96.7%,准确度58.2%
  • 患者水平分析中STIR准确度高于增强T1WI(94.5% vs 78.2%,P=.004),敏感度更高(92.0% vs 64.0%,P=.016),特异度相当(96.7% vs 90.0%,P=.50)
  • 25例同时行两种序列的动眼神经麻痹患者中,STIR在7例(28.0%)显示增强T1WI未见相应异常的影像异常

临床应用与阅片要点

  • 评价动眼神经麻痹时应注意观察眶内段动眼神经STIR高信号
  • 常规增强T1WI未显示异常时,眼眶STIR可能提供补充诊断信息
  • STIR为无对比剂序列,可作为增强检查的补充手段

局限性

  • 回顾性、单中心研究设计
  • 动眼神经麻痹不同病因亚组间的一致性未明确说明

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Oculomotor nerve palsy has diverse etiologies, with MRI, including fat-suppressed contrast-enhanced T1WI, widely used for evaluation. Although intra-orbital oculomotor nerve STIR hyperintensity has been reported in diabetic oculomotor nerve palsy, its consistency across diverse oculomotor nerve palsy etiologies remains unclear. We evaluated this and determined whether orbital STIR provides complementary imaging information in oculomotor nerve palsy evaluation by comparing STIR with a GRE-based contrast-enhanced T1WI protocol.

MATERIALS AND METHODS: This retrospective, single-center study included 31 consecutive patients with oculomotor nerve palsy and 43 normal controls who underwent orbital 2D STIR imaging. The index test was intra-orbital oculomotor nerve STIR hyperintensity; the reference standard was clinical diagnosis. Contrast-enhanced T1WI was available in 25 patients and 30 normal controls. Two neuroradiologists independently evaluated the oculomotor nerve, with emphasis on the intra-orbital segment and supplementary assessment of the cisternal and cavernous segments. Diagnostic performance was assessed using lesion- and patient-based analyses. Sequences were compared using the McNemar test.

RESULTS: A total of 74 participants (31 oculomotor nerve palsy, 43 normal controls; 40 men, 34 women; median age 68 years [interquartile range, 52-76]) were evaluated. In the lesion-based analysis, intra-orbital STIR hyperintensity showed the highest sensitivity and accuracy among the three STIR-evaluated segments as an imaging correlate of clinically diagnosed oculomotor nerve palsy (sensitivity, 90.3%; specificity, 100%; accuracy, 95.9%). In the same segment, GRE-based contrast-enhanced T1WI showed lower sensitivity and accuracy (sensitivity, 12.0%; specificity, 96.7%; accuracy, 58.2%). In the patient-based analysis (n = 55), STIR showed higher accuracy (94.5% vs 78.2%; P = .004) and sensitivity (92.0% vs 64.0%; P = .016), with comparable specificity (96.7% vs 90.0%; P = .50). Among 25 patients with oculomotor nerve palsy evaluated using both sequences, STIR demonstrated imaging abnormalities corresponding to the clinically affected oculomotor nerve in seven patients (28.0%) in whom no corresponding abnormality was identified on contrast-enhanced T1WI.

CONCLUSIONS: Intra-orbital oculomotor nerve STIR hyperintensity was frequently observed across diverse etiologies as an imaging correlate of clinically diagnosed oculomotor nerve palsy. Orbital STIR imaging may serve as a useful non-contrast complement to conventional MRI protocols in the evaluation of oculomotor nerve palsy.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Kasai, Ide, Watanabe, et al. Diagnostic Value of Intra-orbital Oculomotor Nerve Short Tau Inversion Recovery Hyperintensity in Oculomotor Nerve Palsy. AJNR Am J Neuroradiol. 2026. PMID: 42595465. doi:10.3174/ajnr.A9589

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。